Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity

Clinical trial NCT07674290 · RECRUITING

Trial details

NCT number: NCT07674290
Sponsor: Tom Hühne
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Bardet Biedl Syndrome (BBS)Bardet Biedl Syndrome Bardet-Biedl Syndrome (BBS)Alstrom Syndrome

Start date: 2023-01-01
Primary completion: 2030-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.